CPC A61L 27/00 (2013.01) [A61K 9/5115 (2013.01); A61K 9/5123 (2013.01); A61K 9/5138 (2013.01); A61K 33/38 (2013.01); A61K 47/24 (2013.01); A61K 47/32 (2013.01); B22F 1/0545 (2022.01); B22F 1/0551 (2022.01); B22F 1/14 (2022.01); B22F 1/145 (2022.01); B22F 1/147 (2022.01); B22F 1/16 (2022.01); C08J 3/2053 (2013.01); C08K 3/08 (2013.01); C08K 3/28 (2013.01); C08K 3/36 (2013.01); C08K 3/38 (2013.01); C08K 5/092 (2013.01); C08K 5/1535 (2013.01); C09D 125/06 (2013.01); C09D 129/04 (2013.01); C09D 139/06 (2013.01); A61L 2300/104 (2013.01); B22F 1/068 (2022.01); B22F 2301/255 (2013.01); B22F 2998/10 (2013.01); C08J 2325/18 (2013.01); C08J 2329/04 (2013.01); C08K 2003/0806 (2013.01)] | 7 Claims |
1. A process for generating a solution of silver nanoplates comprising the steps of:
forming a plurality of silver seeds from a solution, wherein the solution comprises a reducing agent, a stabilizing agent that is a salt, a polymer, or a biomolecule, and a silver salt;
growing the plurality of silver seeds into a plurality of silver nanoplates in the solution;
adding a buffer to the solution comprising the plurality of silver nanoplates, wherein the buffer is a sulfate, carbonate, chromate, borate, sulfite, acetate, or nitrate buffer; and
concentrating the solution of silver nanoplates until a peak optical density of the solution is greater than about 10 cm−1;
isolating the concentrated silver nanoplates; and
encapsulating the isolated concentrated silver nanoplates with silica, wherein the silver nanoplates are functionalized with a functional group or groups selected from one or more of the following: thiol, acrylate, alkyne, maleimide, silane, azide, hydroxyl, lipid, disulfide, fluorescent molecule, biotin, or combinations thereof.
|